Late treatment study
et al., Cancer Discovery, doi:10.1158/2159-8290.CD-20-0941 (Peer Reviewed)
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study
Retrospective cancer patients, showing adjusted OR 1.03 [0.62-1.73] for HC
Q. The study reports the number of HC
Q+AZ patients but they do not provide results for HC
Q+AZ (only HC
Q + any other treatment). Significant confounding by indication and compassionate use is likely.
death, ↑2.4%, p=0.90
(odds ratio converted to relative risk)
Please send us corrections, updates, or comments.